Photorhabdus Species: Bioluminescent Bacteria as Human Pathogens? by Gerrard, John G. et al.
Emerging Infectious Diseases  •  Vol. 9, No. 2, February 2003 251
DISPATCHES
Photorhabdus
Species:
Bioluminescent
Bacteria as
Emerging Human
Pathogens?
John G. Gerrard,* Samantha McNevin,† 
David Alfredson,* Ross Forgan-Smith,† 
and Neil Fraser‡
We report two Australian patients with soft tissue infections
due to Photorhabdus species. Recognized as important insect
pathogens, Photorhabdus spp. are bioluminescent gram-nega-
tive bacilli. Bacteria belonging to the genus are emerging as a
cause of both localized soft tissue and disseminated infections
in humans in the United States and Australia. The source of
infection in humans remains unknown.
ioluminescence is the production of visible light by a
chemical reaction in a living organism. The property is
rarely reported in the clinical bacteriology laboratory because
bacterial bioluminescence is seen primarily in marine species.
Photorhabdus spp (family: Enterobacteriaceae) are the only
terrestrial bacteria known to exhibit this property (1). The clas-
sification within the genus is complex with three currently rec-
ognized species: P. luminescens,  P. temperata, and P.
asymbiotica (2). Several subspecies are recognized.
Photorhabdus spp. have been the subject of intensive study
by agricultural scientists because of the role these bacteria play
in controlling insects. Insects, like humans, are subject to infes-
tation by nematodes (3). Photorhabdus spp. inhabit the gut of
some insect-pathogenic nematodes (Heterorhabditis spp.),
where they form a symbiotic relationship. Nematode species of
this type are able to invade the larvae of susceptible insects and
release Photorhabdus spp. The bacteria proliferate and promote
nematode reproduction by killing the insect larvae.
Insect-pathogenic nematodes harboring Photorhabdus spp
are used as biopesticides in a number of countries, including
the United States and Australia. Agricultural scientists are also
attempting to develop insect-resistant transgenic crops by using
insecticidal toxin genes derived from Photorhabdus spp. (4). 
Genes encoding homologues of insecticidal toxins from
Photorhabdus spp. occur naturally within the genome of Yers-
inia pestis, the cause of plague. Lateral transfer of genetic
material between Photorhabdus and Yersinia species is
thought to have resulted from their common association with
insects as bacterial pathogens (5).
Human infection with Photorhabdus  spp.  has been
described in two previous publications—six cases from the
United States (6) and four cases from South Eastern Australia
(Victoria and New South Wales) (1). We report two additional
recent human cases of Photorhabdus infection from the Aus-
tralian state of Queensland.
The Study
Patient 1
A 39-year-old male pest controller from Gladstone on a
routine visit to his general practitioner in April 2001 inquired
about the recent appearance of a red macule, 8 mm in diame-
ter, on the medial aspect of his right ankle. No specific treat-
ment was given.  When he was seen again 18 days later, a
painful, necrotic ulcer, about 12 mm in diameter, had devel-
oped at the original site of the red spot. A gram-negative
organism later identified as Photorhabdus sp. was isolated in
pure growth from the exudate. The patient began a 10-day
course of oral cephalexin. When he was observed again 11
days later, he exhibited a persistent discharge with surrounding
cellulitis. He was therefore prescribed a 10-day course of oral
amoxycillin-clavulanate. Three weeks later, the ulcer appeared
to be healing; after another 6 weeks, signs of infection had
again developed. A gram-negative organism was isolated from
the exudate but was not formally identified.
The patient was prescribed an additional 7-day course of
oral cephalexin. When he was observed 3 months later, the
infection had resolved. In his recent work as a pest controller,
he had been spraying chemical insecticides under houses and
in foreign cargo ships. He had never used insect pathogenic
nematodes as a biopesticide.
Patient 2
A 78-year-old man from the Queensland Gold Coast
sought treatment in January 1999 with a 3-day history of a
painful, swollen right foot. The patient had a history of poly-
myalgia rheumatica for which he was taking prednisone, 8 mg
daily. In January 1999, after working barefoot in the garden,
the man noted intense pain in his right forefoot and a very
small amount of bloody discharge from the web space between
his fourth and fifth toes.
The next day he was seen by his general practitioner who
treated him with oral dicloxacillin. Two days later he was
admitted to the hospital with increasingly severe pain with
extensive redness and swelling extending to his right knee. He
was noted to be afebrile with a mild neutrophil leukocytosis.
He was started on a regimen of intravenous dicloxacillin and
gentamicin. 
Surgical debridement of the right foot was required on
three occasions during the first 8 days of his admission. Pus
was collected for culture on two of these occasions, and tissue
was obtained during the third.  An organism identified as
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Photorhabdus sp. was isolated in pure culture from each of
these operative specimens. The same organism was also iso-
lated, together with Staphylococcus aureus, from a superficial
swab collected in the emergency department on presentation.
No bacterial growth was obtained from blood cultures col-
lected on admission.
The patient was treated with intravenous gentamicin for 2
weeks and ceftazidime for 1 week. He was discharged on a 6-
week course of oral ciprofloxacin. The foot remained healed
on follow-up 3 months later.
Photorhabdus spp. can be isolated and identified to genus
level by using techniques available in most clinical bacteriol-
ogy laboratories. A total of five isolates from the two patients
described in the current report were examined in our laborato-
ries with standard techniques (one from patient 1 and four
from patient 2). The phenotypic characteristics that the isolates
displayed were typical of the genus.
Colonies were formed after 24–48 hours on tryptic soy
agar containing either 5% sheep or horse blood (bioMérieux,
Baulkham Hills, Australia) at both 35°C and at room tempera-
ture, with a tendency to “swarm” (Figure 1). The isolates also
grew on MacConkey agar. On sheep and horse blood agar, a
thin line of annular hemolysis was observed 4–12 mm from
the colony edge. The hemolysis was more apparent when the
isolates were incubated at room temperature (Figure 2). The
organisms were motile, gram-negative, rod-shaped bacteria.
They were facultatively anaerobic, oxidase negative, and
strongly catalase positive. Other biochemical reactions were as
described previously (1).
The defining characteristic was the presence of faint lumi-
nescence, which could be clearly seen with the naked eye
when the colonies were examined under conditions of total
darkness. It was critical to this examination that the observer’s
eyes be allowed to adjust to the darkness for 10 minutes.
Two commercially available automated bacterial identifi-
cation systems were used in our laboratories: MicroScan
Walkaway (Dade Behring Inc., MicroScan Division, West
Sacramento, CA) and bioMerieux Vitek (bioMérieux; Hazel-
wood, MO). Photorhabdus spp. do not currently appear on the
databases of either of these systems, which leads to misidenti-
fication (Table 1).
Photorhabdus spp. have been shown to form a heteroge-
neous group based on DNA-DNA hybridization studies, 16S
rDNA sequencing and polymerase chain reaction ribotyping
(2). A polyphasic approach is now applied to classifying iso-
lates within the genus, dividing it into three species and sev-
eral subspecies. The American clinical isolates described by
Farmer et al. (6) belong to a new species, Photorhabdus asym-
biotica (2). A specific epithet has not yet been assigned to the
Australian clinical isolates but they also may form a new spe-
cies within the genus (7).
Antimicrobial sensitivity was assessed by using broth
microdilution. The isolates were sensitive to a broad range of
antimicrobial agents with activity against gram-negative bac-
teria including ciprofloxacin, gentamicin, tetracycline, ceftri-
axone, and amoxycillin-clavulanate. Isolates from both
patients were resistant to cephalothin and ampicillin.
Conclusions
Publication of information about these two cases brings to
a total of 12 the number of human infections with Photorhab-
dus spp. documented in the medical literature (Table 2 and
Figure 3). The clinical picture described in the 12 cases has
generally been one of localized or more commonly multifocal
skin/soft tissue infection. Such infection has had a tendency to
relapse. The disseminated distribution of skin/soft tissue infec-
tion in several cases suggests hematogenous spread. Bactere-
mia was documented in 4/12 case-patients. Cough was
Figure 1. Photorhabdus isolate from patient 2, growing on tryptic soy
agar containing 5% sheep blood, after 48 hours’ incubation at 35°C.
Arrows indicate “swarming.” The colonies could be seen to glow faintly
with the naked eye under conditions of total darkness after 10 minutes
of adjustment.
Figure 2. Photorhabdus isolate from patient 2 after 5 days’ growth at
room temperature on sheep blood agar. Arrows indicate the character-
istic thin line of “annular” hemolysis surrounding the colonies.Emerging Infectious Diseases  •  Vol. 9, No. 2, February 2003 253
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documented in two of the bacteremic case-patients. In one of
these, isolates of a Photorhabdus sp. were obtained from spu-
tum as well as from blood and skin/soft tissue.
Given the very limited clinical experience, making defini-
tive recommendations about treatment is not possible. Antimi-
crobial therapy should be guided by in vitro sensitivities. The
tendency for Photorhabdus infection to relapse suggests that
prolonged therapy for a period of weeks would be prudent,
perhaps with an oral fluoroquinolone.
Photorhabdus  spp.  are not human commensals. The
patients apparently acquired the pathogen from an unidentified
source in the terrestrial environment. This hypothesis is sup-
ported by the observations that at least 4/6 of the Australian
patients were engaged in outdoor activities around the time of
acquisition and that the initial site of infection was on the
lower limbs in more than half of Australian and American
case-patients. 
Photorhabdus spp. have never been shown to live freely in
soil, although they will survive in soil under laboratory condi-
tions (8). Photorhabdus spp. have only been isolated naturally
from two nonclinical sources: insect-pathogenic nematodes
(Heterorhabditis spp) and the insects they parasitize (beetles,
moths, and the like). It seems likely therefore that Photorhab-
dus spp are transmitted to humans by a terrestrial invertebrate
(nematode or arthropod), but that vector has not yet been iden-
tified.
Table 1. Misidentification of Photorhabdus isolates from patients 1 
and 2 by commercially available bacterial identification systems
System Misidentification Probability
MicroScan Walkaway Rapid 
Neg BP Combo Panel Type 4
Shewanella putrefaciens 99.97%
MicroScan Walkaway
Neg BP Combo Panel Type 11
Pseudomonas oryzihabitans 85.46%
BioMérieux Vitek
GNI+ V1316
Providencia stuartii 99%
Figure 3. Australian and American clinical isolates of Photorhabdus.
Table 2. Published human cases of Photorhabdus infection
Case no. Year  Country Location Age/sex Clinical Alleged vector Source of isolate
1 2001 Australia Gladstone, 
Queensland
39M Soft tissue infection right ankle
(professional pest controller)
Pus from ankle ulcer
2 1999 Australia Gold  Coast, 
Queensland
78M Soft tissue infection right foot Pus and tissue from 
right foot 
3 (1) 1998 Australia Murwil-lumbah, 
New South Wales
55M Multifocal soft tissue infections 
(upper and lower limbs, abdomen), 
pneumonia
Blood, sputum, pus 
and tissue
4 (1) 1998 Australia Wangaratta, 
Victoria
50M Multifocal soft tissue infections 
(upper and lower limbs)
Spider Pus from soft tissue 
abscesses
5 (1) 1998 Australia Melbourne, Victoria 90M Cough and fever Blood
6 (1) 1994 Australia Melbourne, Victoria 11F Multifocal soft tissue infections 
(lower limbs and chest)
Pus and soft tissue 
biopsies
7 (6) 1989 USA San Antonio, Texas Groin infection Groin
8 (6) 1987 USA San Antonio, Texas 45M Multifocal soft tissue infection, 
left lower limb
Spider Pus from lower 
limb abscess
9 (6) 1986 USA San Antonio, Texas 78M Multifocal soft tissue infection 
left lower limb
Pus from lower limb 
abscess and ulcer
10 (6) 1984 USA San Antonio, Texas 36F Disseminated bacterial infection Submandible, abdomen
11 (6) 1979 USA Pennsylvania 72F Blood, skin
12 (6) 1977 USA Maryland 80F Endocarditis BloodDISPATCHES
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